Trial intelligence / Profile preview

Malaria Prevention in Pregnancy in Kabale, Uganda

NCT00142207Phase 3Completed

Sponsor
London School of Hygiene & Tropical Medicine
Start
Jan 2004
Primary completion
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of sulfadoxine + pyrimethamine in malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoints: Mean birthweight and Prevalence of low birthweight. Started Jan 2004; status: completed.

02

Drugs

sulfadoxine + pyrimethamine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00142207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00142207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call